Theracrine Inc Cambridge, MA - 02142

Theracrine Inc is categorized under Research and Development Laboratories in Cambridge, MA and active since 2010.

Theracrine Inc was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Steven Kelly at the company’s single location by writing to 1 Memorial Drive, Cambridge, Massachusetts MA 02142 or by phoning (617) 868-1888. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Theracrine Inc
Contact Person: Steven Kelly
Address: 1 Memorial Drive, Cambridge, Massachusetts 02142
Phone Number: (617) 868-1888
Website Address: flagshipventures.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Theracrine Inc was started in 2010 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Steven Kelly for inquiries that concern Theracrine Inc by calling the company number (617) 868-1888, as your correspondence is most welcome. Additionally, the physical location of the single location of Theracrine Inc can be found at the coordinates 42.359998,-71.08342 as well as the street address 1 Memorial Drive in Cambridge, Massachusetts 02142.

For its online presence, you may visit Theracrine Inc’s website at flagshipventures.com and engage with its social media outlets through on Twitter and on Facebook.